Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors

2d ago, source:

Appointment Adds Broad Expertise in Business Strategy, Collaborations, Finance, and M&A with Recent Ophthalmic Experience - ...

Alport Syndrome Market to Witness Upsurge in Growth at a Massive CAGR of 69% by 2034 | DelveInsight

1d ago, source:

DelveInsight's Alport Syndrome Market Insights report includes a comprehensive understanding of current treatment practices, ...

Ocular Drug Delivery Market Rising Vistas Exploring Future Market Size for Unlocking Growth

7d ago, source: Taiwan News

Alimera Sciences, Inc. is a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and ...

Phase III win for Intra-Cellular's Caplyta for major depressive disorder

2d ago, source: BioWorld

Robust top-line phase III data showed Intra-Cellular Therapies Inc.’s marketed oral atypical antipsychotic drug, Caplyta (lumateperone), achieved statistically significant and clinically meaningful ...

DelveInsight Business Research, LLP: Usher Syndrome Market to Exhibit Growth at a CAGR of 10.55% by 2034 | DelveInsight

7d ago, source:

The dynamics of the Usher syndrome market are anticipated to change rapidly in the coming years owing to the anticipated launch of emerging therapies that have shown positive outcomes in clinical ...

DelveInsight Business Research, LLP: Alport Syndrome Market to Witness Upsurge in Growth at a Massive CAGR of 69% by 2034 | DelveInsight

1d ago, source:

The dynamics of the Alport syndrome market are anticipated to change in the coming years owing to the improvement in the rise in healthcare spending across the world. LAS VEGAS, April ...